CJC-1295 W/ DAC
đź“ť LAB NOTES
CJC-1295 with DAC is a synthetic growth hormone-releasing hormone (GHRH) analog studied for its ability to stimulate and sustain growth hormone (GH) and insulin-like growth factor-1 (IGF-1) signaling. The Drug Affinity Complex (DAC) extends the peptide's biological half-life, making it of particular research interest for investigating prolonged growth hormone secretion, endocrine signaling, body composition, recovery-related pathways, and metabolic processes.
TARGETED RESEARCH USE
Growth hormone and IGF-1 signaling, prolonged GHRH activity, endocrine pathways, body composition, muscle-related research, recovery mechanisms, protein synthesis, lipid metabolism, and age-related changes in growth hormone secretion.
RESEARCH REFERENCES
Teichman SL, Neale A, Lawrence B, Gagnon C, Castaigne JP, Frohman LA. Prolonged Stimulation of Growth Hormone (GH) and Insulin-Like Growth Factor I Secretion by CJC-1295, a Long-Acting Analog of GH-Releasing Hormone, in Healthy Adults. Journal of Clinical Endocrinology & Metabolism. 2006;91(3):799–805.View Study on PubMed
Jette L, Leger R, Thibaudeau K, et al. Human Growth Hormone-Releasing Factor (hGRF)1-29-Albumin Bioconjugates Activate the GRF Receptor on the Anterior Pituitary in Rats: Identification of CJC-1295 as a Long-Lasting GRF Analog. Endocrinology. 2005;146(7):3052–3058.View Study on PubMed
Ionescu M, Frohman LA. Pulsatile Secretion of Growth Hormone (GH) Persists During Continuous Stimulation by CJC-1295, a Long-Acting GH-Releasing Hormone Analog. Journal of Clinical Endocrinology & Metabolism. 2006;91(12):4792–4797.View Study on PubMed
⚠️ FOR RESEARCH USE ONLY — NOT FOR HUMAN OR ANIMAL USE
This research compound is supplied as a lyophilized powder in a sealed 3 mL vial to support stability and proper laboratory handling. Certificate of Analysis (COA) available for verification. Reconstitution is required prior to research use.